1. |
Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2):69-90.
|
2. |
張澍田. 重視消化道早期癌的診治[J]. 中華消化內鏡雜志, 2010, 27(9):449-450.
|
3. |
單勇, 李玉民, 李汛, 等. 甘肅胃癌高發區人群p53基因Arg72Pro多態性的初步研究[J]. 中國普外基礎與臨床雜志, 2009, 16(1):12-17.
|
4. |
Iwaki N, Karatsu K, Miyamoto M. Role of guanine nucleotide exchange factors for Rho family GTPases in the regulation of cell morphology and actin cytoskeleton in fission yeast[J]. Biochem Biophys Res Commun, 2003, 312(2):414-420.
|
5. |
Durkin ME, Avner MR, Huh CG, et al. DLC-1, a Rho GTPase-activating protein with tumor suppressor function, is essential for embryonic development[J]. FEBS Lett, 2005, 579(5):1191-1196.
|
6. |
van Nieuw Amerongen GP, Koolwijk P, Versteilen A, et al. Involvement of RhoA/Rho kinase signaling in VEGF-induced endothelial cell migration and angiogenesis in vitro[J]. Arterioscler Thromb Vasc Biol, 2003, 23(2):211-217.
|
7. |
Sun HW, Tong SL, He J, et al. RhoA and RhoC -siRNA inhibit the proliferation and invasiveness activity of human gastric carci-noma by Rho/PI3K/Akt pathway[J]. World J Gastroenterol, 2007, 13(25):3517-3522.
|
8. |
Della Peruta M, Giagulli C, Laudanna C, et al. RHOA and PRKCZ control different aspects of cell motility in pancreatic cancermetastatic clones[J]. Mol Cancer, 2010, 9:61.
|
9. |
王康康, 李建生, 祁代華. 肝細胞癌RhoA SLP-2蛋白的表達及其臨床意義[J]. 中國實用內科雜志, 2009, 29(5):460-462.
|
10. |
Gómez del Pulgar T, Benitah SA, Valerón PF, et al. Rho GTPaseexpression in tumourigenesis:evidence for a significant link[J]. Bioessays, 2005, 27(6):602-613.
|
11. |
Huber MA, Kraut N, Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression[J]. Curr Opin Cell Biol, 2005, 17(5):548-558.
|
12. |
熊正文, 曹莉, 胡海霞, 等. Snail和VEGF基因在乳腺浸潤性導管癌中表達研究[J]. 中國普外基礎與臨床雜志, 2011, 18(11):1194-1199.
|
13. |
Côme C, Magnino F, Bibeau F, et al. Snail and slug play distinctroles during breast carcinoma progression[J]. Clin Cancer Res, 2006, 12(18):5395-5402.
|
14. |
Volm M, Koomägi R, Mattern J. Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer[J]. Int J Cancer, 1997, 74(1):64-68.
|
15. |
Struckhoff AP, Rana MK, Worthylake RA. RhoA can lead the way in tumor cell invasion and metastasis[J]. Front Biosci, 2011, 16:1915-1926.
|
16. |
Jian M, Nan L, Guocheng J, et al. Downregulating PRL-3 inhibit migration and invasion of lung cancer cell via RhoA and mDia1[J]. Tumori, 2012, 98(3):370-376.
|
17. |
Ma L, Liu YP, Zhang XH, et al. Relationship of RhoA signaling activity with ezrin expression and its significance in the prognosis for breast cancer patients[J]. Chin Med J (Engl), 2013, 126(2):242-247.
|
18. |
Nguyen QD, De Wever O, Bruyneel E, et al. Commutators of PAR-1 signaling in cancer cell invasion reveal an essential role ofthe Rho-Rho kinase axis and tumor microenvironment[J]. Onco-gene, 2005, 24(56):8240-8251.
|
19. |
潘陽林, 畢鋒, 劉娜, 等. Rho家族蛋白在胃癌細胞系中的表達及意義[J]. 解放軍醫學雜志, 2003, 28(6):517-519.
|
20. |
Cai J, Niu X, Chen Y, et al. Emodin-induced generation of reac-tive oxygen species inhibits RhoA activation to sensitize gastric carcinoma cells to anoikis[J]. Neoplasia, 2008, 10(1):41-51.
|
21. |
羅丕丹, 羅毅, 麥昌季. 胃癌組織RhoA 蛋白表達的意義[J]. 第四軍醫大學學報, 2009, 30(12):1067.
|
22. |
Cho SG, Li D, Stafford LJ, et al. KiSS1 suppresses TNFα-induced breast cancer cell invasion via an inhibition of RhoA-mediated NF-κB activation[J]. J Cell Biochem, 2009, 107(6):1139-1149.
|
23. |
Cowell CF, Yan IK, Eiseler T, et al. Loss of cell-cell contacts induces NF-κB via RhoA-mediated activation of protein kinase D1[J]. J Cell Biochem, 2009, 106(4):714-728.
|
24. |
Hall A. Rho GTPases and the control of cell behaviour[J]. Bio-chem Soc Trans, 2005, 33(Pt 5):891-895.
|